share_log

SVB Securities Maintains Outperform on AlloVir, Raises Price Target to $19

Benzinga ·  Apr 26, 2023 10:36

SVB Securities analyst Mani Foroohar maintains AlloVir (NASDAQ:ALVR) with a Outperform and raises the price target from $16 to $19.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment